author-photo

Charles D. Webb

Baptist Memorial Hospital-Memphis

21

Papers

244

Citations

Citation Trend

Filter By

Papers (16) Sort By

Journal Conference Others

Phase II studies of AZD1775, a WEE1 kinase inhibitor, and chemotherapy in non-small-cell lung cancer (NSCLC): Lead-in cohort results

2016 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Abstract P5-14-04: A phase 2 study evaluating orteronel, an inhibitor of androgen biosynthesis, in patients with androgen receptor (AR)-expressing metastatic breast cancer: Interim analysis

2016 Cancer Research
Show All
- Source
- Cite
- Save
Citations (2)
Abstract P1-12-04: A phase 2 study of eribulin in breast cancer not achieving a pathologic complete response (pCR) to neoadjuvant chemotherapy (NAC)

2016 Cancer Research
Show All
- Source
- Cite
- Save
Citations (1)
Sorafenib and Everolimus in Advanced Clear Cell Renal Carcinoma: A Phase I/II Trial of the SCRI Oncology Research Consortium

2013 Cancer Investigation
Show All
- Source
- Cite
- Save
Citations (19)
A Phase II Trial of Preoperative Concurrent Chemotherapy/Radiation Therapy Plus Bevacizumab/Erlotinib in the Treatment of Localized Esophageal Cancer

2012 Clinical advances in hematology & oncology
Show All
- Source
- Cite
- Save
Citations (48)
Phase II trial of ixabepilone and carboplatin with or without bevacizumab in patients with previously untreated advanced non-small-cell lung cancer

2012 Lung Cancer
Show All
- Source
- Cite
- Save
Citations (13)
Abstract P1-14-14: Neoadjuvant Sunitinib (S) Administered with Weekly Paclitaxel (P)/Carboplatin(C) in Patients (Pts) with Locally Advanced Triple-Negative Breast Cancer (TNBC): Preliminary Results from a Phase I/II Trial of the Sarah Cannon Research Institute.

2012 Cancer Research
Show All
- Source
- Cite
- Save
Citations (1)
Phase II trial of ixabepilone and carboplatin with or without bevacizumab in patients with previously untreated advanced non-small cell lung cancer.

2010 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (3)
Phase II Trial of Weekly Docetaxel, Vinorelbine, and Trastuzumab in the First-Line Treatment of Patients with HER2-Positive Metastatic Breast Cancer

2009 Clinical Breast Cancer
Show All
- Source
- Cite
- Save
Citations (26)
Phase II Trial of Docetaxal Plus Imatinib Mesylate in the Treatment of Patients With Metastatic Breast Cancer

2009 Clinical Breast Cancer
Show All
- Source
- Cite
- Save
Citations (28)